Astria Therapeutics

Yahoo Finance • 12 days ago

Halper Sadeh LLC Encourages ATXS, PCH, RYN Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • last month

HALPER SADEH LLC ENCOURAGES PLYM, HOLX, ATXS, PCH SHAREHOLDERS to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies fo... Full story

Yahoo Finance • last month

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sotherly Hotels Inc. (Nasdaq – SOHO), Hologic, Inc. (Nasdaq – HOLX), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

BALA CYNWYD, Pa., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • last month

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hologic, Inc. (Nasdaq – HOLX), TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)

BALA CYNWYD, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 2 months ago

Key deals this week: Paramount Skydance, PotlatchDeltic, Brighthouse Financial, Papa John's and more

Here's a list of key deals reported across sectors this week: * Paramount Skydance (NASDAQ:PSKY [https://seekingalpha.com/symbol/PSKY]) is preparing a second bid [https://seekingalpha.com/news/4503595-paramount-skydance-preparing-second... Full story

Yahoo Finance • 2 months ago

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates RYN, PCH, ATXS on Behalf of Shareholders

NEW YORK, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE, AKRO, PCH, ATXS on Behalf of Shareholders

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), SWK Holdings Corporation (Nasdaq – SWKH)

BALA CYNWYD, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 2 months ago

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ATXS and RYN on Behalf of Shareholders

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 months ago

BioCryst to buy Astria Therapeutics for $13 per share (update)

_UPDATE: ADDS SHARE MOVEMENTS_ BioCryst Pharmaceuticals (NASDAQ:BCRX [https://seekingalpha.com/symbol/BCRX]) has agreed to acquire biopharmaceutical firm Astria Therapeutics (NASDAQ:ATXS [https://seekingalpha.com/symbol/ATXS]) for a mix o... Full story

Yahoo Finance • 2 months ago

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile

– Deal to add navenibart, a late-stage and long-acting plasma kallikrein inhibitor, in Phase 3 clinical development, to BioCryst’s HAE portfolio – – Solidifies double digit growth trajectory for HAE portfolio over the next decade – – Bio... Full story

Yahoo Finance • 3 months ago

Shift4 Payments Becomes Oversold (FOUR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 3 months ago

Trump to impose tariffs on semiconductor imports from companies not moving production to the US

U.S. President Donald Trump said on Thursday that his administration would impose tariffs on semiconductor imports from companies not shifting production to the U.S. “Yeah, I have discussed it with the people here. Chips and semiconductor... Full story

Yahoo Finance • 4 months ago

Astria Therapeutics stock price target raised to $26 by JMP on HAE program progress

Investing.com - JMP Securities raised its price target on Astria Therapeutics (NASDAQ:ATXS) to $26.00 from $25.00 on Wednesday, while maintaining a Market Outperform rating on the stock. According to InvestingPro data, analysts remain high... Full story

Yahoo Finance • 4 months ago

Astria Therapeutics Inc (NASDAQ:ATXS) Reports Narrower-Than-Expected Q2 2025 Loss and Strong Cash Runway

ASTRIA THERAPEUTICS REPORTS Q2 2025 RESULTS: NARROWER-THAN-EXPECTED LOSS, CASH RUNWAY EXTENDED Astria Therapeutics (NASDAQ:ATXS [https://www.chartmill.com/stock/quote/ATXS]) reported a net loss of $0.57 per share for the second quarter of... Full story

Yahoo Finance • 4 months ago

Astria TherapeuticS GAAP EPS of -$0.57 beats by $0.02

* Astria TherapeuticS press release [https://seekingalpha.com/pr/20198655-astria-therapeutics-reports-second-quarter-2025-financial-results-and-provides-a-corporate] (NASDAQ:ATXS [https://seekingalpha.com/symbol/ATXS]): Q2 GAAP EPS of -$... Full story

Yahoo Finance • 6 months ago

Astria stock rises as H.C. Wainwright reiterates buy rating

Astria Therapeutics (NASDAQ:ATXS) stock rose Monday following H.C. Wainwright’s reiteration of a buy rating and $16.00 price target on the company’s shares. According to InvestingPro data, analysts’ targets range from $16 to $47, with a st... Full story

Yahoo Finance • 3 years ago

10 Best Immunology Stocks to Invest In

In this article, we discuss the 10 best immunology stocks to invest in. If you want to read about some more immunology stocks, go directly to 5 Best Immunology Stocks to Invest In. Immunology is the study of the immune system of higher or... Full story